Patients Must Be Warned of Breast Implant Risks, F.D.A. Says

The New York Times, October 27, 2021: The FDA has placed black box warnings on breast implant packaging and told manufacturers to sell the implants only to health providers who review the potential risks with patients before surgery, and tell them the risks are even higher for breast cancer patients. The National Center for Health Research asks who will enforce that?

Read More »